CARDIOSIGNAL (€1.96M as coordinator) develops breakthrough apps to detect cardiac conditions for stroke and heart attack prevention.
PRECORDIOR OY
Finnish health-tech SME developing cardiac monitoring apps built on MEMS and photonics sensor technology.
Their core work
Precordior is a Finnish health technology SME that develops cardiac monitoring applications capable of detecting conditions linked to stroke and heart attacks. Their core work combines MEMS sensor technology and photonics with medical device development, bridging advanced semiconductor packaging with real-world clinical applications. They bring expertise in miniaturized sensor systems — including light sensors, thermal infrared sensors, and related optics — into the medical device domain. Their flagship effort, CARDIOSIGNAL, focuses on breakthrough mobile apps for early cardiac condition detection.
What they specialise in
APPLAUSE and CARDIOSIGNAL both involve MEMS, light sensors, and optics applied to compact sensing devices.
APPLAUSE focuses on advanced packaging for photonics, optics, and electronics for low-cost European manufacturing.
Moore4Medical participation targets accelerating innovation in microfabricated medical devices.
How they've shifted over time
Precordior's H2020 involvement is concentrated in a narrow 2019–2020 window, so dramatic evolution is limited. Their early projects (APPLAUSE, 2019) show roots in photonics hardware — semiconductor manufacturing, optics, thermal infrared sensors, and datacom transceivers. By 2020, they shifted decisively toward medical applications, coordinating CARDIOSIGNAL and joining Moore4Medical, signaling a clear pivot from component-level sensor work to end-user health technology products.
Precordior is moving from sensor hardware toward integrated medical device applications, particularly mobile cardiac diagnostics — a direction that positions them at the intersection of medtech and consumer health.
How they like to work
With 1 coordinated project out of 3, Precordior takes leadership when the topic aligns with their core cardiac monitoring mission, while joining as a specialist partner in broader platform projects. Their 86 unique consortium partners across 16 countries indicate participation in large Innovation Action consortia, suggesting comfort operating within complex multi-partner projects. For an SME of this size, their network breadth is notable and reflects an outward-looking, collaboration-ready approach.
Despite only 3 projects, Precordior has built a network of 86 partners across 16 countries, driven by participation in large Innovation Action consortia in the photonics and medtech sectors. Their geographic reach spans broadly across Europe with no single dominant partner country beyond Finland.
What sets them apart
Precordior occupies a rare niche: they combine deep MEMS and photonics sensor expertise with direct application in cardiac health monitoring — few SMEs bridge advanced semiconductor packaging and consumer medical diagnostics. Their willingness to coordinate a €1.96M project demonstrates ambition and capability beyond a typical sensor component supplier. For consortium builders, they offer a partner who understands both the hardware fabrication chain and the clinical end-use requirements.
Highlights from their portfolio
- CARDIOSIGNALTheir largest project (€1.96M) and only coordinated effort — directly reflects their core mission of cardiac condition detection via mobile apps.
- APPLAUSEPositions Precordior within the European photonics packaging ecosystem, connecting their sensor hardware roots to a broader manufacturing supply chain.